- Home
- PLX vs SUP Comparison
PLX vs SUP Comparison
Compare PLX & SUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- SUP
- Stock Information
- Founded
- PLX 1993
- SUP 1957
- Country
- PLX Israel
- SUP United States
- Employees
- PLX N/A
- SUP N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- SUP Auto Parts:O.E.M.
- Sector
- PLX Health Care
- SUP Consumer Discretionary
- Exchange
- PLX Nasdaq
- SUP Nasdaq
- Market Cap
- PLX 79.4M
- SUP 87.5M
- IPO Year
- PLX 1998
- SUP N/A
- Fundamental
- Price
- PLX $1.68
- SUP $2.42
- Analyst Decision
- PLX
- SUP Buy
- Analyst Count
- PLX 0
- SUP 1
- Target Price
- PLX N/A
- SUP $11.00
- AVG Volume (30 Days)
- PLX 439.0K
- SUP 103.4K
- Earning Date
- PLX 11-14-2024
- SUP 11-07-2024
- Dividend Yield
- PLX N/A
- SUP N/A
- EPS Growth
- PLX N/A
- SUP N/A
- EPS
- PLX N/A
- SUP N/A
- Revenue
- PLX $45,667,000.00
- SUP $1,265,637,000.00
- Revenue This Year
- PLX N/A
- SUP $0.34
- Revenue Next Year
- PLX $88.94
- SUP $7.91
- P/E Ratio
- PLX N/A
- SUP N/A
- Revenue Growth
- PLX N/A
- SUP N/A
- 52 Week Low
- PLX $0.82
- SUP $2.10
- 52 Week High
- PLX $1.90
- SUP $4.57
- Technical
- Relative Strength Index (RSI)
- PLX 74.56
- SUP 36.73
- Support Level
- PLX $1.14
- SUP $2.30
- Resistance Level
- PLX $1.75
- SUP $2.48
- Average True Range (ATR)
- PLX 0.12
- SUP 0.15
- MACD
- PLX 0.05
- SUP -0.02
- Stochastic Oscillator
- PLX 87.29
- SUP 21.43
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About SUP Superior Industries International Inc. (DE)
Superior Industries International Inc is engaged in the design and manufacture of aluminum wheels for sale to OEMs in North America and Europe and to the aftermarket in Europe. The company's OEM aluminum wheels are primarily sold for factory installation on vehicle models manufactured by BMW (including Mini), Daimler (Mercedes-Benz, AMG, Smart), Ford, GM, Honda, Jaguar-Land Rover, Lucid Motors, Mazda, Nissan, PSA, Renault, Stellantis, Subaru, Suzuki, Toyota, VW Group (Volkswagen, Audi, SEAT, Skoda, Porsche, Bentley) and Volvo. It sells aluminum wheels to the European aftermarket under the brands ATS, RIAL, ALUTEC, and ANZIO.